News Releases Year: - Any -202020192018201720162015201420132012 Items per page 102550 10/30/20 Summary ToggleClearside Biomedical to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Tuesday, November 10, 2020 PDF Version 09/23/20 Summary ToggleClearside Biomedical Announces Clinical Data Presentations at The Retina Society 2020 and Publication of XIPERE™ Data in Diabetic Macular Edema in Ophthalmology Retina PDF Version 09/11/20 Summary ToggleClearside Biomedical’s Oncology Licensing Partner Doses First Patient in its Phase 2 Study in Patients with Choroidal Melanoma Using SCS Microinjector® for Suprachoroidal Delivery PDF Version 09/09/20 Summary ToggleClearside Biomedical to Present at the Virtual H.C. Wainwright 22nd Annual Global Investment Conference PDF Version 09/09/20 Summary ToggleClearside Biomedical’s Licensing Partner Doses First Patient in its Phase 2 Gene Therapy Trial Using SCS Microinjector® for Suprachoroidal Delivery PDF Version 08/26/20 Summary ToggleClearside Biomedical Expands Patent Portfolio in the U.S. and Europe PDF Version 08/10/20 Summary ToggleClearside Biomedical Announces Second Quarter 2020 Financial Results and Provides Corporate Update PDF Version 08/10/20 Summary ToggleClearside Biomedical Announces U.S. FDA Acceptance of Investigational New Drug Application for CLS-AX (axitinib injectable suspension) Administered in Suprachoroidal Space PDF Version 08/04/20 Summary ToggleClearside Biomedical to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference PDF Version 07/30/20 Summary ToggleClearside Biomedical to Report Second Quarter 2020 Financial Results and Provide Corporate Update on Monday, August 10, 2020 PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 Next page Last page Last
